APA

Moldovan D., Reshef A., Fabiani J., Kivity S., Toubi E., Shlesinger M., Triggiani M., Montinaro V., Cillari E., Realdi G., Cancian M., Visscher S., Zanichelli A., Relan A. & Cicardi M. (20130108). Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Chicago

Moldovan D, Reshef A, Fabiani J, Kivity S, Toubi E, Shlesinger M, Triggiani M, Montinaro V, Cillari E, Realdi G, Cancian M, Visscher S, Zanichelli A, Relan A and Cicardi M. 20130108. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Harvard

Moldovan D., Reshef A., Fabiani J., Kivity S., Toubi E., Shlesinger M., Triggiani M., Montinaro V., Cillari E., Realdi G., Cancian M., Visscher S., Zanichelli A., Relan A. and Cicardi M. (20130108). Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

MLA

Moldovan D, Reshef A, Fabiani J, Kivity S, Toubi E, Shlesinger M, Triggiani M, Montinaro V, Cillari E, Realdi G, Cancian M, Visscher S, Zanichelli A, Relan A and Cicardi M. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 20130108.